Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share (GENB)

Q: What does CUSIP 370920100 represent in this 13F holders report?

CUSIP 370920100 is the security identifier for GENB - Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held GENB - Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share in Q1 2026?

57 institutional investors reported GENB - Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 370920100

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, $0.001 par value per share
Total 13F shares: 92,824,382
Total 13F value: $1,157,381,584
Share change: +92,674,382
SEC-reported price per share: $12.50
Number of holders: 57
Value change: +$1,155,506,583
Number of buys: 54
Shares outstanding: 128,224,775

Security key

370920100

Report period

Q1 2026

Institutions

Top holders

GENB full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Generate Biomedicines, Inc. SEC filings Generate Biomedicines, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 370920100

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of GENB - Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Flagship Pioneering, LLC

Disclosed value leader

Flagship Pioneering, LLC

Comparable rows

2/15

Latest evidence

31 Mar 2026

13D/G 3/4/5 Lead comparable stake: 49% 13 rows are not safely comparable across share classes. 13D/G row: Flagship Pioneering, LLC Showing 1-6 of 15 holder rows.

Quick read

Flagship Pioneering, LLC leads the comparable SEC ownership view at 49%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flagship Pioneering, LLC's linked filing trail.

Comparable ownership Top 2

Flagship Pioneering, LLC 49%

Michael Nally 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Flagship Pioneering, LLC	13D/G Afeyan Noubar 13D/G	49%	$802,584,512 62,701,915 shares	$0	31 Mar 2026
Michael Nally	13D/G 3/4/5 Nally Michael · Chief Executive Officer, Director 13D/G 3/4/5	5.2%	$88,563,853 6,919,051 shares	$0	31 Mar 2026
Ph.D. Noubar B. Afeyan	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	— 62,702,678 shares mixed-class rows	—	26 Feb 2026
Pioneering Medicines 02, LLC	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 1,562,500 shares	—	02 Mar 2026
Stephane Bancel	3/4/5 Director 3/4/5	— mixed-class rows	— 1,214,550 shares mixed-class rows	—	26 Feb 2026
Gevorg Grigoryan	3/4/5 Chief Technology Officer 3/4/5	— mixed-class rows	— 856,341 shares mixed-class rows	—	26 Feb 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

92,824,382

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend